|
Volumn 33, Issue 1, 2013, Pages 271-272
|
The role of interleukin-23/interleukin-17 axis in the development of systemic lupus erythematosus among patients with tuberculosis: Comment on: Lin YC, Liang SJ, Liu YH et al.: Tuberculosis as a risk factor for systemic lupus erythematosus: Results of a nationwide study in Taiwan. (Rheumatol Int. 2011 Mar 18. [Epub ahead of print])
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GAMMA INTERFERON;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 17;
INTERLEUKIN 23;
TRANSCRIPTION FACTOR TWIST;
TRANSCRIPTION FACTOR TWIST 1;
UNCLASSIFIED DRUG;
B LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CELL DIFFERENTIATION;
CELL SURVIVAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE COURSE;
EX VIVO STUDY;
GRANULOMA;
HIGH RISK PATIENT;
HUMAN;
HUMAN CELL;
IMMUNOPATHOGENESIS;
LETTER;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TH1 CELL;
TH17 CELL;
TISSUE INJURY;
TUBERCULOSIS;
ENDEMIC DISEASES;
FEMALE;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MALE;
TUBERCULOSIS;
|
EID: 84872339211
PISSN: 01728172
EISSN: 1437160X
Source Type: Journal
DOI: 10.1007/s00296-011-2226-y Document Type: Letter |
Times cited : (1)
|
References (7)
|